Oxetorone
Title: Oxetorone
CAS Registry Number: 26020-55-3
CAS Name: 3-Benzofuro[3,2-c][1]benzoxepin-6(12H)-ylidene-N,N-dimethyl-1-propanamine
Additional Names: N,N-dimethylbenzofuro[3,2-c][1]benzoxepin-D6(12H),g-propylamine; 6-(3-dimethylaminopropylidene)benzo[b]benzofurano[2,3-e]oxepine
Molecular Formula: C21H21NO2
Molecular Weight: 319.40
Percent Composition: C 78.97%, H 6.63%, N 4.39%, O 10.02%
Literature References: Novel serotonin and histamine antagonist with antimigraine activity. Prepn: F. Binon, M. Descamps, DE 1963205 corresp to US 3651051 (1970, 1972 both to Labaz). Metabolism in vitro: E. Rossi et al., J. Chromatogr. 152, 228 (1978). Use in treatment of migraine: J. J. Dufresne, Praxis 67, 1148 (1978); J. Florence, ibid. 1323; in chronic headache: U. Thoden, Therapiewoche 30, 492 (1980).
 
Derivative Type: Fumarate
CAS Registry Number: 34522-46-8
Manufacturers' Codes: L-6257
Trademarks: Nocertone (Labaz); Oxedix (Labaz)
Molecular Formula: C25H25NO6
Molecular Weight: 435.47
Percent Composition: C 68.95%, H 5.79%, N 3.22%, O 22.04%
Properties: Cryst from isopropanol, mp 160°.
Melting point: mp 160°
 
Therap-Cat: Analgesic (specific in migraine).
Keywords: Antimigraine; Serotonin Receptor Antagonist.

Others monographs:
PurpurogallinLactaroviolinBismuth AluminateStramonium
CephalothinNormetanephrineCrocetinFedotozine
MeprylcaineCalcium MesoxalateTung OilSulforidazine
TedisamilClobetasolAcitretinα-Picoline
©2016 DrugLead US FDA&EMEA